Academic medical journals are pushing for new tougher standards on drug industry-backed articles which they consider for publication following criticism of their policies. That comes in the wake of several well-publicized studies which omitted negative side effects of prescription drugs. Both the British Medical Journal (BMJ) and the Journal of the American Medical Association (JAMA) are requiring that authors certify the integrity of the data they include. Both journals are asking authors for more information to ensure that study results are not skewed or influenced by outside interests, and are asking that early study plans be submitted together with completed projects.
- see this story from the Wall Street Journal. (subscription req.)